Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Helicobacter pylori membrane proteins are a heterogeneous group of proteins essential for the bacterium's ability to colonize and persist in the human gastric mucosa. This group includes outer membrane proteins (OMPs) such as adhesins (e.g., BabA, SabA), which mediate binding to host glycoconjugates, and porins (e.g., Hop proteins) that facilitate the diffusion of small molecules (PubMed: 21819461). These proteins are vital for maintaining structural integrity, acquiring nutrients, and defending against the acidic environment of the stomach through mechanisms like urea transport for the urease enzyme (PubMed: 10456913). In the context of disease, they are central to the inflammatory response and the delivery of virulence factors that lead to gastritis, peptic ulcers, and gastric cancer (PubMed: 25452551). As they are exposed on the bacterial surface, they serve as major targets for both the host immune system and pharmacological interventions, including traditional antibiotics and emerging vaccine candidates (PubMed: 30202473). Targeting these proteins aims to disrupt bacterial adhesion, metabolism, or structural integrity to eradicate the infection and prevent associated diseases.
Inhibition of cell wall synthesis via penicillin-binding proteins, disruption of protein synthesis by binding to the 50S ribosomal subunit, and interference with DNA integrity (StatPearls: NBK544281). Additionally, some agents disrupt the bacterial membrane or inhibit the urease-mediated acid resistance mechanism (PubMed: 10456913).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Helicobacter pylori membrane protein (H. pylori OMP).